cbdMD, Inc. (YCBD) |
|
0.3499 0.005 (1.42%)
|
02-03 13:48 |
|
Open: |
0.3422 |
Pre. Close: |
0.345 |
|
High:
|
0.35 |
Low:
|
0.33 |
|
Volume:
|
47,808 |
Market Cap:
|
21(M) |
|
|
|
Technical analysis |
as of: 2023-02-03 1:51:06 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 0.43 One year: 0.5 |
| Support: |
Support1: 0.27 Support2: 0.21 |
| Resistance: |
Resistance1: 0.37 Resistance2: 0.43 |
| Pivot: |
0.32  |
| Moving Average: |
MA(5): 0.33 MA(20): 0.3
MA(100): 0.27 MA(250): 0.48  |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 74.6 %D(3): 79.9 |
| RSI: |
RSI(14): 63 |
| 52-week: |
High: 1.29 Low: 0.2 |
| Average Vol(K): |
3-Month: 244 (K) 10-Days: 222 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ YCBD ] has closed below upper band by 6.8%. Bollinger Bands are 50.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.35 - 0.35 |
0.35 - 0.35 |
|
Low:
|
0.32 - 0.32 |
0.32 - 0.32 |
|
Close:
|
0.34 - 0.34 |
0.34 - 0.35 |
|
Company Description |
|
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina. |
Headline News |
Thu, 26 Jan 2023
2023-01-26 | NYSEAM:YCBD | Press Release | cbdMD Inc. - Stockhouse
Thu, 19 Jan 2023
cbdMD Inc (YCBD) Stock Gains 24.00% This Week: Is It a Good Pick? - InvestorsObserver
Thu, 12 Jan 2023
Is cbdMD Inc (YCBD) a Stock to Watch After Gaining 16.67% This Week? - InvestorsObserver
Wed, 11 Jan 2023
cbdMD Welcomes Shannon Charles as Chief Marketing Officer - InvestorsObserver
Tue, 10 Jan 2023
Should You Accumulate cbdMD Inc (YCBD) Stock Tuesday? - InvestorsObserver
Fri, 16 Dec 2022
cbdMD, Inc. (YCBD) Q4 2022 Earnings Call Transcript - Seeking Alpha
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
58 (M) |
| Shares Float |
39 (M) |
|
% Held by Insiders
|
32.1 (%) |
|
% Held by Institutions
|
22.3 (%) |
|
Shares Short
|
2,070 (K) |
|
Shares Short P.Month
|
1,020 (K) |
Stock Financials |
|
EPS
|
-0.48 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.77 |
|
Profit Margin (%)
|
-52.6 |
|
Operating Margin (%)
|
-44.1 |
|
Return on Assets (ttm)
|
-10.4 |
|
Return on Equity (ttm)
|
-25.7 |
|
Qtrly Rev. Growth
|
-16.3 |
|
Gross Profit (p.s.)
|
0.51 |
|
Sales Per Share
|
0.76 |
|
EBITDA (p.s.)
|
-0.32 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-14 (M) |
|
Levered Free Cash Flow
|
-7 (M) |
Stock Valuations |
|
PE Ratio
|
-0.75 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.19 |
|
Price to Sales
|
0.45 |
|
Price to Cash Flow
|
-1.45 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
